Danish company will be first to market with oral obesity treatment but rival Eli Lilly is not far behind
Novo Nordisk weight-loss drug wins US approval as a daily pill
Recent Posts
- Inner London house prices fall at fastest rate since global financial crisis
- Bessent says Deutsche chief distanced bank from research note on US assets
- Trump’s ‘wrecking ball’ set to touch down in Davos
- Howard Lutnick heckled at World Economic Forum dinner
- UK inflation rises more than expected to 3.4% in December
